Amphetamine discrimination: effects of dopamine receptor agonists
- 1 January 1989
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 160 (2) , 253-262
- https://doi.org/10.1016/0014-2999(89)90498-6
Abstract
No abstract availableThis publication has 22 references indexed in Scilit:
- The discriminative stimulus properties of the D-1 agonist SK&F 38393 and the D-2 agonist (−)-NPA are mediated by separate mechanismsLife Sciences, 1988
- Comparison of the pharmacological characteristics of [3H]raclopride and [3H]SCH 23390 binding to dopamine receptors in vivo in mouse brainEuropean Journal of Pharmacology, 1988
- Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonistsEuropean Journal of Pharmacology, 1987
- Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in ratsEuropean Journal of Pharmacology, 1987
- Obligatory D-1/D-2 receptor interaction in the generation of dopamine agonist related behaviorsEuropean Journal of Pharmacology, 1986
- Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinitiesin vitroJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1986
- Dopaminergic mechanisms and motor function: Characterization of D-1 and D-2 dopamine receptor interactionsEuropean Journal of Pharmacology, 1986
- A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatumLife Sciences, 1985
- Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neurolepticsLife Sciences, 1984
- Analyzing mechanism(s) of hallucinogenic drug action with drug discrimination proceduresNeuroscience & Biobehavioral Reviews, 1982